These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 1895305

  • 1. N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor.
    Thompson RD, Secunda S, Daly JW, Olsson RA.
    J Med Chem; 1991 Sep; 34(9):2877-82. PubMed ID: 1895305
    [Abstract] [Full Text] [Related]

  • 2. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists.
    Ukena D, Padgett WL, Hong O, Daly JW, Daly DT, Olsson RA.
    FEBS Lett; 1987 May 11; 215(2):203-8. PubMed ID: 3582647
    [Abstract] [Full Text] [Related]

  • 3. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
    Müller CE, Hide I, Daly JW, Rothenhäusler K, Eger K.
    J Med Chem; 1990 Oct 11; 33(10):2822-8. PubMed ID: 2213835
    [Abstract] [Full Text] [Related]

  • 4. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors.
    Olsson RA, Kusachi S, Thompson RD, Ukena D, Padgett W, Daly JW.
    J Med Chem; 1986 Sep 11; 29(9):1683-9. PubMed ID: 3018244
    [Abstract] [Full Text] [Related]

  • 5. Agonist activity of 2- and 5'-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1- and A2-adenosine receptors coupled to adenylate cyclase.
    Daly JW, Padgett WL.
    Biochem Pharmacol; 1992 Mar 03; 43(5):1089-93. PubMed ID: 1554381
    [Abstract] [Full Text] [Related]

  • 6. Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors.
    Thompson RD, Secunda S, Daly JW, Olsson RA.
    J Med Chem; 1991 Dec 03; 34(12):3388-90. PubMed ID: 1766003
    [Abstract] [Full Text] [Related]

  • 7. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
    Sarges R, Howard HR, Browne RG, Lebel LA, Seymour PA, Koe BK.
    J Med Chem; 1990 Aug 03; 33(8):2240-54. PubMed ID: 2374150
    [Abstract] [Full Text] [Related]

  • 8. Adenosine receptors: development of selective agonists and antagonists.
    Daly JW, Jacobson KA, Ukena D.
    Prog Clin Biol Res; 1987 Aug 03; 230():41-63. PubMed ID: 3588607
    [Abstract] [Full Text] [Related]

  • 9. Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.
    Jacobson KA, Siddiqi SM, Olah ME, Ji XD, Melman N, Bellamkonda K, Meshulam Y, Stiles GL, Kim HO.
    J Med Chem; 1995 May 12; 38(10):1720-35. PubMed ID: 7752196
    [Abstract] [Full Text] [Related]

  • 10. 2-Chloro-N6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors.
    Lohse MJ, Klotz KN, Schwabe U, Cristalli G, Vittori S, Grifantini M.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun 12; 337(6):687-9. PubMed ID: 3216901
    [Abstract] [Full Text] [Related]

  • 11. 7-Deaza-9-phenyladenines. A new class of adenosine receptor antagonists.
    Daly JW, Padgett WL, Eger K.
    Biochem Pharmacol; 1988 Oct 01; 37(19):3749-53. PubMed ID: 3178888
    [Abstract] [Full Text] [Related]

  • 12. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
    Shimada J, Suzuki F, Nonaka H, Ishii A.
    J Med Chem; 1992 Mar 06; 35(5):924-30. PubMed ID: 1548682
    [Abstract] [Full Text] [Related]

  • 13. Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
    Daly JW, Padgett WL, Shamim MT.
    J Med Chem; 1986 Jul 06; 29(7):1305-8. PubMed ID: 3806581
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
    Bruns RF, Lu GH, Pugsley TA.
    Mol Pharmacol; 1986 Apr 06; 29(4):331-46. PubMed ID: 3010074
    [Abstract] [Full Text] [Related]

  • 15. Identification of the A2 adenosine receptor binding subunit by photoaffinity crosslinking.
    Barrington WW, Jacobson KA, Hutchison AJ, Williams M, Stiles GL.
    Proc Natl Acad Sci U S A; 1989 Sep 06; 86(17):6572-6. PubMed ID: 2771944
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the adenosine receptor in cultured embryonic chick atrial myocytes: coupling to modulation of contractility and adenylate cyclase activity and identification by direct radioligand binding.
    Liang BT.
    J Pharmacol Exp Ther; 1989 Jun 06; 249(3):775-84. PubMed ID: 2732946
    [Abstract] [Full Text] [Related]

  • 17. Desensitization of adenosine A2 receptors in the striatum of the rat following chronic treatment with diazepam.
    Hawkins M, Pan W, Stefanovich P, Radulovacki M.
    Neuropharmacology; 1988 Nov 06; 27(11):1131-40. PubMed ID: 2849727
    [Abstract] [Full Text] [Related]

  • 18. Influence of the molecular structure of N6-(omega-aminoalkyl)adenosines on adenosine receptor affinity and intrinsic activity.
    Pirovano IM, IJzerman AP, Van Galen PJ, Soudijn W.
    Eur J Pharmacol; 1989 May 11; 172(2):185-93. PubMed ID: 2767141
    [Abstract] [Full Text] [Related]

  • 19. Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.
    Boring DL, Ji XD, Zimmet J, Taylor KE, Stiles GL, Jacobson KA.
    Bioconjug Chem; 1991 May 11; 2(2):77-88. PubMed ID: 1868116
    [Abstract] [Full Text] [Related]

  • 20. Structure-activity relationships for 2-substituted adenosines at A1 and A2 adenosine receptors.
    Daly JW, Padgett WL, Secunda SI, Thompson RD, Olsson RA.
    Pharmacology; 1993 May 11; 46(2):91-100. PubMed ID: 8441759
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.